Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002117599-26-000002
Filing Date
2026-03-10
Accepted
2026-03-10 16:11:31
Documents
3
Period of Report
2026-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1773173487.html 3  
1 FORM 3 wk-form3_1773173487.xml 3 19458
2 EX-24 supernus-toddhorichpoa.htm EX-24 3536
3 GRAPHIC supernus-toddhorichpoa001.jpg GRAPHIC 177639
  Complete submission text file 0002117599-26-000002.txt   269334
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Horich William Todd (Reporting) CIK: 0002117599 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35518 | Film No.: 26739380